Revenue: The sum of all revenue fields included for a company's operating activities.
Arcus Biosciences, Inc. (RCUS) had Revenue of $31.00M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$31.00M |
$-81.00M |
|
-- |
|
$31.00M |
|
$122.00M |
|
$-91.00M |
|
$11.00M |
|
$-80.00M |
|
$-80.00M |
|
$-81.00M |
|
$-81.00M |
|
$-81.00M |
|
$-81.00M |
|
$-91.00M |
|
$-94.00M |
|
74.00M |
|
74.00M |
|
$-1.08 |
|
$-1.08 |
|
| Balance Sheet Financials | |
$831.00M |
|
$51.00M |
|
$264.00M |
|
$1.09B |
|
$184.00M |
|
-- |
|
$449.00M |
|
$633.00M |
|
$462.00M |
|
$462.00M |
|
$462.00M |
|
75.50M |
|
| Cash Flow Statement Financials | |
$-306.00M |
|
$194.00M |
|
$33.00M |
|
$209.00M |
|
$130.00M |
|
$-79.00M |
|
$73.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-293.55% |
|
-293.55% |
|
-- |
|
-258.06% |
|
-261.29% |
|
$-330.00M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.82 |
|
110.32 |
|
-17.53% |
|
-17.53% |
|
-7.40% |
|
-17.53% |
|
$6.12 |
|
$-4.46 |
|
$-4.14 |
|